Blog
Month: May 2019

Cell therapy and gene therapy versus cancer: 10 numbers to watch

Blog

ASCO 2019 is here! In 2018, ASCO named CAR-T cell therapy the cancer Advance of the Year, and this year’s ASCO brings more cell...

When the patient is the product — some key challenges in cell and gene therapies

Blog

In personalized therapies — cell therapies, gene therapies, and neoantigen therapies — a patient is not just the recipient of...

Cell and gene therapy standards need you!

Blog

One week to go! In the next seven days, those of us working in cell and gene therapy have a...

Supply chain management readiness, Part 2: operational ecosystem

Blog

(Note: this post is the second part of a four-part series on supply chain planning for personalized therapies such as...

Cell and gene therapy news: some recent highlights

Blog

Things keep moving fast in the world of cell and gene therapy. Here are a few of the recent developments...

Commercial lessons for clinical-phase success, Part I: it all starts with collaboration

Blog

In early-phase clinical research, it’s common to think that your science resides within your lab. But when it comes to...